Skip to main content
PLOS One logoLink to PLOS One
. 2021 Apr 5;16(4):e0249807. doi: 10.1371/journal.pone.0249807

Correction: Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity

Ryosuke Seki, Akira Ohta, Akira Niwa, Yoshinori Sugimine, Haruna Naito, Tatsutoshi Nakahata, Megumu K Saito
PMCID: PMC8021175  PMID: 33819274

The affiliation for the third author is incorrect. Akira Niwa is not affiliated with #2 but with #1: Department of Clinical Application, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.

Reference

  • 1.Seki R, Ohta A, Niwa A, Sugimine Y, Naito H, Nakahata T, et al. (2020) Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity. PLoS ONE 15(8): e0237030. 10.1371/journal.pone.0237030 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES